1 / 3

x100

C. pT3: single nodule, tumor diameter: 7 cm vp1+ vv0 b0 im -. pT3: single nodule, tumor diameter: 5 cm vp1+ vv0 b0 im -. A. HLA class I high PD-L1 high. HLA class I high PD-L1 low. x20. No recurrence. Recurrence on day180 after hepatectomy. D. B. x100.

angeni
Download Presentation

x100

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. C pT3: single nodule, tumor diameter:7 cm vp1+ vv0 b0im- pT3: single nodule, tumor diameter:5 cm vp1+ vv0 b0im- A HLA class Ihigh PD-L1 high HLA class Ihigh PD-L1 low x20 No recurrence Recurrence on day180 after hepatectomy D B x100 Supplementary Figure S2 (continued) Umemoto et al. Impact of PD-L1 in Class I-positive HCC

  2. E G x100 F H x200 Supplementary Figure S2 Umemoto et al. Impact of PD-L1 in Class I-positive HCC

  3. Legend for Supplementary Figure S2. Sections showing HCC specimens derived from patients No.1875 (A, B, E, F; PD-L high/HLA class I high) and 1959 (C, D, G, H; PD-L1 low/HLA class I high) stained with H&E (A-D) and antibody to CD3 (E-H). Degenerative changes, necrosis, and necrosis of the HCC were prominent (arrow, C, D) and associated with massive infiltration of CD3-positive cells (G, H) in patient 1959, but were minimal (A, B) and associated with infiltration of a few CD3-positive cells only in the peripheral tissue of the tumor in patient 1875 (E, F). Despite similar characteristics of the tumor factors, patient 1959 showed no evidence of tumor recurrence, whereas patient 1959 showed HCC recurrence 180 days after curative hepatectomy.

More Related